Lisata Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €3.10M +8.1% -€33.90M +36.8% -1,093.1% -2.3 pp N/A N/A
    (estimated) €2.87M +∞% -€24.79M -10.2% -864.0% -8.6 pp -€8.63M -53.5% -300.9% -3.0 pp
    (estimated) €0.00 -100.0% -€27.60M +55.0% N/A -€18.57M +10.3% N/A
    (estimated) €25.85K -97.0% -€17.80M +3.4% -68,866.7% -670 pp -€16.83M +1.0% -65,133.3% -630 pp
    €861.55K +∞% -€17.22M -4.1% -1,998.5% -20 pp -€16.68M -3.4% -1,935.6% -19 pp
    €0.00 -100.0% -€17.95M -61.6% N/A -€17.26M -4.1% N/A
    €104.57M +∞% -€46.72M +97.4% -44.7% -0.45 pp -€17.99M -5.9% -17.2% -0.17 pp
    €0.00 +NaN% -€23.66M +237.0% N/A -€19.11M +152.0% N/A
    €0.00 +NaN% -€7.02M -59.5% N/A -€7.58M -53.4% N/A
    €0.00 +NaN% -€17.32M +24.3% N/A -€16.27M -4.9% N/A
    €0.00 +NaN% -€13.93M -170.4% N/A -€17.10M -4.3% N/A
    €0.00 -100.0% €19.80M -170.4% N/A -€17.87M -0.4% N/A
    €30.40M +56.9% -€28.13M -59.6% -92.6% +2.7 pp -€17.94M -42.3% -59.0% +1.0 pp
    €19.37M +25.4% -€69.69M +47.4% -359.7% -0.54 pp -€31.08M -16.6% -160.4% +0.81 pp
    €15.46M +22.3% -€47.28M +40.8% -305.9% -0.40 pp -€37.25M +77.1% -241.0% -0.75 pp
    €12.64M +2.4% -€33.58M -28.8% -265.7% +1.2 pp -€21.03M +83.2% -166.4% -0.73 pp
    €12.35M +42.6% -€47.20M +16.2% -382.3% +0.87 pp -€11.48M -34.5% -93.0% +1.1 pp
    €8.66M -85.6% -€40.61M +102.2% -469.0% -4.4 pp -€17.54M -357.6% -202.5% -2.1 pp
    €60.15M +503.7% -€20.08M -10.9% -33.4% +1.9 pp €6.81M -226.2% 11.3% +0.65 pp
    €9.96M +13,743.5% -€22.55M +183.2% -226.3% +110 pp -€5.39M +32.6% -54.1% +56 pp
    €71.97K -63.9% -€7.96M -11.5% -11,062.9% -66 pp -€4.07M -21.5% -5,652.8% -31 pp
    €199.59K +406.7% -€9.00M +72.6% -4,508.9% +87 pp -€5.18M +67.3% -2,596.2% +53 pp
    €39.39K +29.7% -€5.21M +246.8% -13,233.8% -83 pp -€3.10M +331.1% -7,863.9% -55 pp
    €30.38K -27.4% -€1.50M -0.2% -4,948.8% -13 pp -€718.53K -42.7% -2,365.1% +6.3 pp
    €41.84K -24.9% -€1.51M +67.4% -3,600.4% -20 pp -€1.25M +42.9% -2,999.0% -14 pp
    €55.68K -20.5% -€899.58K -10.0% -1,615.5% -1.9 pp -€878.20K -201.3% -1,577.1% -28 pp
    €70.09K -24.3% -€999.26K -42.9% -1,425.8% +4.7 pp €867.16K -375.9% 1,237.3% +16 pp
    €92.57K -79.8% -€1.75M +0.3% -1,892.1% -15 pp -€314.28K -81.3% -339.5% +0.27 pp
    €458.13K +4,036.9% -€1.75M +82.2% -381.2% +83 pp -€1.68M -2,599.6% -366.8% -9.7 pp
    €11.07K +∞% -€958.33K -165.0% -8,653.6% -87 pp €67.24K -109.4% 607.1% +6.1 pp
    €0.00 -100.0% €1.47M -150.8% N/A -€714.67K +107.4% N/A
    €18.14M +177.3% -€2.90M -∞% -16.0% -0.16 pp -€344.62K -141.2% -1.9% -0.15 pp
    €6.54M €0.00 0.0% €835.70K 12.8%

    Notifications